GleamWall
中文EN

SKIN SkinHealth Systems Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1818093 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.4%
TTM net income YoY-55.7%
TTM EPS YoY117.5%
Revenue 3-yr CAGR-10.3%
Net income 3-yr CAGR—

Margins

Gross margin67.2%
Operating margin2.4%
Net margin-6.3%
FCF margin7.9%
EBITDA margin3.2%

Returns

ROE-30.1%
ROA-4.1%
ROIC (approx.)7.1%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets85.7%
Debt / equity0.00x
Current ratio2.89x
Interest coverage0.27x

Cash quality & payout

Operating cash flow / net income-1.29x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$69.17M$72.11M$64.91M$82.37M$70.66M$78.19M$69.58M$83.50M
Cost of revenue$22.02M$22.77M$20.47M$29.33M$25.02M$29.07M$21.00M$31.15M
Gross profit$47.15M$49.34M$44.44M$53.04M$45.63M$49.11M$48.58M$52.35M
R&D expense$1.66M$1.41M$1.10M$1.68M$1.70M$1.25M$998,000$1.22M
SG&A expense$20.50M$23.34M$21.94M$27.68M$29.25M$27.45M$33.56M$31.76M
Operating income$4.98M$3.57M-$1.80M$162,000-$6.24M-$2.70M-$12.02M-$7.16M
Interest expense$6.27M$6.29M$6.35M$6.37M$6.31M$4.14M$2.50M$2.46M
Pretax income-$108,000-$1.46M-$6.81M-$4.81M-$10.64M$18.72M-$9.20M-$11.72M
Income tax$780,000$1.21M-$184,000$3.30M$386,000-$993,000$892,000-$1.39M
Net income-$888,000-$2.67M-$6.63M-$8.10M-$11.03M$19.71M-$10.10M-$10.33M
EBITDA$5.53M$4.10M-$1.24M$806,000-$5.61M-$1.99M-$10.17M-$5.70M
EPS (basic)-0.14-0.02-0.05—-1.740.16-0.08—
EPS (diluted)-0.14-0.02-0.05—-1.740.03-0.08—
Weighted avg. shares (diluted)6.51M129.60M131.40M—6.35M140.29M125.08M—
Balance sheet
Cash & equivalents$112.39M$206.07M$204.36M$232.67M$219.40M$212.00M$373.03M$370.06M
Receivables$18.47M$17.64M$18.61M$21.74M$22.21M$25.05M$23.26M$27.64M
Inventory$46.25M$46.84M$47.69M$48.01M$56.15M$59.19M$65.63M$69.11M
Current assets$201.59M$295.24M$277.69M$309.52M$308.37M$306.11M$469.37M$477.12M
PP&E, net$1.85M$2.09M$2.34M$2.54M$3.05M$3.70M$4.22M$5.98M
Goodwill$126.12M$126.35M$126.25M$126.62M$126.50M$126.27M$124.26M$123.50M
Intangibles$27.61M$30.22M$32.80M$35.76M$37.98M$43.49M$45.65M$47.51M
Total assets$389.06M$486.57M$473.23M$499.80M$503.64M$507.56M$673.82M$685.68M
Current liabilities$69.84M$168.20M$155.20M$186.28M$61.90M$59.44M$62.80M$68.15M
Long-term debt————$363.39M$363.10M—$552.20M
Total debt————$363.39M$363.10M—$552.20M
Total liabilities$333.31M$431.00M$417.99M$438.75M$437.98M$433.56M$627.76M$633.88M
Shareholders' equity$55.76M$55.57M$55.24M$61.06M$65.66M$74.00M$46.06M$51.80M
Net debt————$143.99M$151.10M—$182.13M
Shares outstanding6.51M130.10M129.14M6.38M127.30M126.76M125.25M124.92M
Cash flow statement
Operating cash flow$11.26M$2.67M-$5.55M$15.20M$9.65M$9.65M$3.00M$16.47M
Capital expenditure$93,000$427,000$224,000$139,000$27,000$92,000$45,000$74,000
Free cash flow$11.17M$2.24M-$5.78M$15.06M$9.62M$9.55M$2.95M$16.40M
Investing cash flow-$1.06M-$1.21M-$1.65M-$1.38M-$1.08M-$1.55M-$1.15M-$862,000
Financing cash flow-$103.51M-$224,000-$20.91M-$512,000-$803,000-$173.36M-$250,000-$770,000
Depreciation & amortization$552,000$529,000$563,000$644,000$637,000$711,000$1.86M$1.45M
Stock-based compensation$1.44M$2.90M$2.08M$3.58M$2.46M$5.31M$3.48M$5.85M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.